KING SKYFRONT, Japan Publishes the December 2019 Issue of Kawasaki SkyFront i-Newsletter: Drug Delivery Technology to Deliver Drugs to the Brain

Tuesday, December 17, 2019 Drug News
Email Print This Page Comment bookmark
Font : A-A+

KAWASAKI, Japan, Dec. 17, 2019 /PRNewswire/ -- The December 2019 issue of Kawasaki SkyFront i-Newsletter includes a video interview on gene therapy with Mariko Tosu, Ph.D., President & CEO Braizon Therapeutics. Inc.; news updates; and highlights of research being conducted by scientists affiliated with Kawasaki INnovation Gateway at SKYFRONT (KING SKYFRONT)—the City's flagship science and technology innovation hub focused on the life sciences and environment.

December 2019 issue of Kawasaki SkyFront iNewsletter

http://inewsletter-king-skyfront.jp/en/

The Kawasaki INnovation Gateway at SKYFRONT (KING SKYFRONT) was launched by Kawasaki City in 2013 as a base for scholars, industrialists and government administrators to work together to devise real life solutions to global issues in the life sciences and environment.

KING SKYFRONT is a 40 hectare area located in the Tonomachi area of the Keihin Industrial Region that spans Tokyo and Kanagawa Prefecture and Tokyo International Airport (Haneda Airport) and an important initiative in establishing the Tonomachi area of Kawasaki City as Asia's Silicon Valley.

Contents of the 17th issue of Kawasaki SkyFront i-Newsletter

Video Feature

Mariko Tosu, Ph.D.President & CEO, Braizon Therapeutics. Inc.Drug delivery technology to deliver drugs to the brainhttp://inewsletter-king-skyfront.jp/en/video_feature/vol-17-feature01/

Research Highlight

A gene-therapy approach for treating spinal cord injury

Delivery of messenger-RNA to the spinal cord through direct injection enhances motor function recovery after spinal cord injury in mice

http://inewsletter-king-skyfront.jp/en/research_highlights/vol-17-research01/

News and Events

JSR to establish the new JSR Bioscience and Informatics R & D Center in Tonomachi, Kawasaki City

http://inewsletter-king-skyfront.jp/en/news/20191111/

Keio University, Bank of Yokohama and Kawasaki City Institute of Industrial Promotion concluded a memorandum of understanding towards industrial promotion of Kawasaki City

http://inewsletter-king-skyfront.jp/en/news/20191107/

PeptiDream and JSR Initiate a Joint Development Program to Identify Peptides Applicable to Affinity Chromatography

http://contents.xj-storage.jp/xcontents/45870/3487fb4a/fef0/4928/9e4f/defceac682c7/20190920093142583s.pdf

AccuRna signs Feasibility Study Agreement with Astellas Innovation Management LLC

https://accurna.com/wp/wp-content/uploads/2019/08/EN_20190820.pdf

About KING SKYFRONT

The Kawasaki INnovation Gateway (KING) SKYFRONT is the flagship science and technology innovation hub of Kawasaki City. KING SKYFRONT is a 40 hectare area located in the Tonomachi area of the Keihin Industrial Region that spans Tokyo and Kanagawa Prefecture and Tokyo International Airport (also often referred to as Haneda Airport).

KING SKYFRONT was launched in 2013 as a base for scholars, industrialists and government administrators to work together to devise real life solutions to global issues in the life sciences and environment.

Further information

Kawasaki City, Japan, Coastal Area International Strategy Headquarters, International Strategy Promotion Department, KING-SKYFRONT Management Center, City of Kawasaki, RGBT2 1A, 3-25-10, Tonomachi, Kawasaki-ku, Kawasaki-City, Kanagawa, 210-0821 Japan.

EMAIL: 59kings@city.kawasaki.jp

Cision View original content:http://www.prnewswire.com/news-releases/king-skyfront-japan-publishes-the-december-2019-issue-of-kawasaki-skyfront-i-newsletter-drug-delivery-technology-to-deliver-drugs-to-the-brain-300975895.html

SOURCE KING SKYFRONT



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
Premium Membership Benefits

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store